Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring risk factors associated with catastrophic health expenditure on diarrhea management in Karachi, Pakistan, 2022-2024.

PLOS global public health·2026
Same author

The consequences of <i>Shigella</i> medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study.

EClinicalMedicine·2026
Same author

Frequency and correlates of non-receipt of age-appropriate vaccination among children aged 6-35 months with medically attended diarrhea: Findings from the Enterics for Global Health (EFGH) Shigella study, 2022-2024.

PLOS global public health·2026
Same author

Use of antibiotic-loaded bone cement for paediatric chronic osteomyelitis: a scoping review.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Combined application of hot water and salicylic acid treatment preserves postharvest quality of mangoes.

Scientific reports·2026
Same author

Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study.

PLoS neglected tropical diseases·2026

Related Experiment Video

Updated: May 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K

Efficacy and immunogenicity of RTS,S/AS01 and R21/Matrix-M malaria vaccines: - Systematic review and meta-analysis.

Hafsah Asjad1, Muhammad Wahhaab Sadiq1, Saba Siddiqui1

  • 1Department of Paediatrics and Child Health, Aga Khan University Hospital, National Stadium Rd, Karachi, Sindh 74800, Pakistan.

Journal of Infection and Public Health
|April 19, 2026
PubMed
Summary

The RTS,S/AS01 and R21/Matrix-M malaria vaccines show promise in reducing malaria risk. Both vaccines are safe and effective, with R21/Matrix-M demonstrating higher efficacy but more adverse events.

Keywords:
EfficacyImmunogenicityMalaria vaccineR21/Matrix-MRTS,S/ASO1

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
05:22

A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses

Published on: November 4, 2025

977

Related Experiment Videos

Last Updated: May 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
05:22

A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses

Published on: November 4, 2025

977

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Malaria remains a significant global health challenge despite ongoing control efforts.
  • Novel vaccines like RTS,S/AS01 and R21/Matrix-M offer potential for reducing the parasite reservoir.
  • Evaluating and comparing these leading malaria vaccines is crucial for public health strategies.

Purpose of the Study:

  • To systematically review and compare the efficacy and immunogenicity of the RTS,S/AS01 and R21/Matrix-M malaria vaccines.
  • To assess the protective effects and safety profiles of the two novel malaria vaccines.
  • To provide an updated comparison of leading malaria vaccine candidates.

Main Methods:

  • A comprehensive literature search was conducted across PubMed, Scopus, and Cochrane databases (2000-2024).
  • Initial screening of 832 records, followed by full-text review of 60 articles.
  • Eight studies were included in the final systematic review and meta-analysis based on eligibility criteria.

Main Results:

  • RTS,S/AS01 vaccine demonstrated significant protection in infants (6-12 weeks) with a 23.0% malaria risk reduction (RR 0.77).
  • Both vaccines showed a 0.61 risk ratio for malaria in the 5-17 month age group, with efficacy waning over time, highlighting the need for boosters.
  • RTS,S/AS01 vaccines were safe with strong antibody responses; R21/Matrix-M showed high efficacy (low event rate 0.22) and robust antibody response but reported more frequent adverse events.

Conclusions:

  • Both RTS,S/AS01 and R21/Matrix-M vaccines represent significant advancements in malaria control.
  • These breakthrough malaria vaccines are instrumental in reducing disease burden and mortality.
  • The findings support the potential of these vaccines for malaria elimination efforts.